A detailed history of Xcel Wealth Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Xcel Wealth Management, LLC holds 7,790 shares of BMY stock, worth $418,790. This represents 0.1% of its overall portfolio holdings.

Number of Shares
7,790
Previous 10,455 25.49%
Holding current value
$418,790
Previous $566,000 42.93%
% of portfolio
0.1%
Previous 0.18%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 23, 2024

SELL
$40.25 - $52.99 $107,266 - $141,218
-2,665 Reduced 25.49%
7,790 $323,000
Q1 2024

Apr 22, 2024

SELL
$47.98 - $54.4 $72,689 - $82,416
-1,515 Reduced 12.66%
10,455 $566,000
Q4 2023

Jan 29, 2024

SELL
$48.48 - $57.85 $154,893 - $184,830
-3,195 Reduced 21.07%
11,970 $614,000
Q3 2023

Oct 17, 2023

SELL
$57.89 - $64.73 $837,726 - $936,707
-14,471 Reduced 48.83%
15,165 $880,000
Q2 2023

Jul 26, 2023

SELL
$63.71 - $70.74 $32,683 - $36,289
-513 Reduced 1.7%
29,636 $1.9 Million
Q1 2023

Apr 25, 2023

SELL
$65.71 - $74.53 $14,916 - $16,918
-227 Reduced 0.75%
30,149 $2.09 Million
Q4 2022

Jan 19, 2023

SELL
$68.48 - $81.09 $167,776 - $198,670
-2,450 Reduced 7.46%
30,376 $2.19 Million
Q3 2022

Oct 20, 2022

SELL
$0.13 - $76.84 $1,194 - $705,775
-9,185 Reduced 21.86%
32,826 $2.33 Million
Q2 2022

Jul 26, 2022

SELL
$72.62 - $79.98 $3.09 Million - $3.41 Million
-42,609 Reduced 50.35%
42,011 $3.24 Million
Q1 2022

Apr 29, 2022

SELL
$61.48 - $73.72 $5.55 Million - $6.66 Million
-90,290 Reduced 51.62%
84,620 $6.18 Million
Q4 2021

Feb 03, 2022

BUY
$53.63 - $62.52 $551,906 - $643,393
10,291 Added 6.25%
174,910 $10.9 Million
Q3 2021

Oct 21, 2021

BUY
$59.17 - $69.31 $1.58 Million - $1.85 Million
26,623 Added 19.29%
164,619 $9.74 Million
Q2 2021

Jul 15, 2021

SELL
$61.91 - $67.42 $928,340 - $1.01 Million
-14,995 Reduced 9.8%
137,996 $9.22 Million
Q1 2021

Apr 15, 2021

BUY
$59.34 - $66.74 $2.06 Million - $2.31 Million
34,645 Added 29.27%
152,991 $9.66 Million
Q4 2020

Jan 13, 2021

BUY
$57.74 - $65.43 $84,300 - $95,527
1,460 Added 1.25%
118,346 $7.34 Million
Q3 2020

Oct 27, 2020

BUY
$57.43 - $63.64 $931,227 - $1.03 Million
16,215 Added 16.11%
116,886 $7.05 Million
Q2 2020

Jul 10, 2020

BUY
$54.82 - $64.09 $1.35 Million - $1.58 Million
24,612 Added 32.36%
100,671 $5.92 Million
Q1 2020

Apr 07, 2020

BUY
$46.4 - $67.43 $2.63 Million - $3.82 Million
56,648 Added 291.83%
76,059 $4.24 Million
Q4 2019

Jan 09, 2020

BUY
$49.21 - $64.19 $955,215 - $1.25 Million
19,411 New
19,411 $1.25 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $114B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Xcel Wealth Management, LLC Portfolio

Follow Xcel Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xcel Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Xcel Wealth Management, LLC with notifications on news.